Quidel | QDEL - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
Agilent USD 465M 11M 2026-03
Avanos Medical USD 77.7M 1.1M 2026-03
Becton, Dickinson and Co. USD 1.21B 180M 2026-03
Bruker USD 242.1M 5.1M 2026-03
Cerus USD 19.33M 1.55M 2024-12
Charles River Laboratories USD 159.42M 36.71M 2026-03
Danaher USD 1.86B 166M 2026-03
Haemonetics USD 109.15M 7.54M 2025-12
Illumina USD 272M 11M 2026-03
IQVIA Holdings USD 502M 34M 2026-03
Merit Medical Systems USD 110.47M 4.36M 2026-03
Mettler Toledo International USD 258.33M 1.5M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
Neogen USD 98.5M 9M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quidel USD 199.3M 4.9M 2026-03
Revvity USD 253.88M 2.15M 2026-03
STAAR Surgical USD 38.64M 299K 2026-03
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Waters USD 394M 153.99M 2026-03